INSIGHTS ON DRUG DEVELOPMENT
-
Application Of LC-UV/MS Workflows To Increase Efficiency
Discover how LC-UV/MS workflows help overcome analytical challenges in GLP-1 analog development to streamline impurity identification and boost lab efficiency in research.
-
Label-Free Analysis Of Multiple Spheroids In A Matrix
Gain insight into how automated z-stack imaging and AI-based analysis enable accurate, label-free monitoring of spheroid development in 3D matrices for drug screening and cell culture workflows.
-
Cell Culture Media Filtration: Evaluating Cell Culture Performance
Cell culture performance remained consistent across PES and PVDF filters, even under worst-case filtration conditions. Discover a practical framework for evaluating membrane impact on CHO cell growth.
-
A Fast And Simple ddPCR Assay For In-Depth AAV Characterization
Achieve precise AAV characterization with a streamlined digital assay. This video illustrates a rapid, four-step workflow that delivers accurate empty-to-full ratios in under eight hours.
-
Sterilization Of APIs – The Alternative: Sterile Filtration Following Aseptic Processing5/21/2026
When terminal sterilization isn't an option for heat- or radiation-sensitive APIs, sterile filtration with aseptic processing protects quality. Get the technical framework.
-
Overcoming Food Effects, Variability, Solubility For A Non-Opioid Analgesic With Lipid-Based Formulations3/20/2026
Develop optimized lipid-based formulations to overcome solubility, stability, and food-effect challenges, enabling high-dose oral delivery and rapid progression to Phase 1 trials.
-
Temperature Dependence On Reversed-Phase Separations7/17/2025
Column temperature critically affects the reversed-phase separation of fatty acid-modified GLP-1 RAs and impurities. Learn how precise control enhances resolution and reproducibility.
-
Coordinated Development As An Execution Framework6/9/2026
See how integrating clinical, development, manufacturing, and supply functions within a single execution framework can transform program performance and accelerate development success.
-
Advancing Cell Therapies With Lipid Nanoparticles3/24/2025
Cell therapies, using reprogrammed immune cells, offer innovative treatments for diseases. Discover how lipid nanoparticles (LNPs) enhance these therapies by delivering RNA for gene modulation and next-gen treatments.
DRUG DEVELOPMENT SOLUTIONS
-
Waters MaxPeak Premier Columns and Solutions dramatically reduce NSA with MaxPeak High Performance Surfaces, innovative technologies designed to reduce analyte loss due to analyte/surface interactions.
-
The SpectraMax® Mini Multi-Mode Microplate Reader
Perform your favorite applications including ELISA, DNA and protein quantitation, cell viability, gene expression with a user-friendly reader.
-
Integrated lab services deliver method development, validation, and testing across modalities, supporting quality, compliance, and formulation progress from early development to commercialization.
-
Explore chemical probes that are selective small-molecule modulators of a protein’s function.
-
At Acceleration Hub, we work with emerging biotech companies and large pharma partners, combining route selection, process development, analytical capabilities, and manufacturing into one coordinated approach - including expertise in highly potent APIs and controlled substances.
With experienced teams, established processes, and dedicated infrastructure, we enable efficient project progression under tight timelines and evolving requirements.